Literature DB >> 24984967

Pregnancy and primary biliary cirrhosis: a case-control study.

Annarosa Floreani1, Chiara Infantolino, Irene Franceschet, Ivette Magne Tene, Nora Cazzagon, Alessandra Buja, Vincenzo Baldo, M Eric Gershwin, Maria Teresa Gervasi.   

Abstract

A very critical feature in women's health is the identification of risk factors for pregnancy and adverse fetal outcome. Primary biliary cirrhosis is an autoimmune disease of the liver that predominantly affects older women. However, the serologic onset of this disease appears to precede clinical manifestations by many years. The goal of this case controlled study was to analyze fertility in primary biliary cirrhosis (PBC) and investigate the outcome of pregnancy, and the influence of pregnancy on the course of the disease. The study included 233 consecutive female patients with PBC seen between 1987 and 2012. Among them, 186 had at least one conception and were matched for age with a 1:2 group of controls (367 healthy women with at least one conception in their life). PBC patients experienced 507 pregnancies as opposed to 700 pregnancies among controls (mean 1.91 vs 2.73, p < 0.05). The two groups' life history was similar in terms of miscarriages, voluntary interruptions of pregnancy, and term and preterm deliveries. The rates for one or more cesarean deliveries were lower for PBC patients (5.7 vs 11.7 %, p < 0.05). Pruritus during pregnancy was recorded in 15 pregnancies involving 13 PBC patients (3.0 %) and none of the controls. Perinatal and postnatal deaths and complications at childbirth were only recorded in the PBC patients, involving a total of 11 babies (2.7 %, p < 0.05). Eight pregnancies occurred after PBC was diagnosed in six patients, all of which had a favorable course at term, with no complications at childbirth. Ursodeoxycholic acid was continued during pregnancy and no exacerbation of the disease was observed. In conclusion, successful completion of pregnancy is a realistic expectation for PBC patients, though pregnancy and delivery must be monitored for the potentially higher than normal risk of childbirth complications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24984967     DOI: 10.1007/s12016-014-8433-z

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  46 in total

1.  Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort.

Authors:  M I Prince; A Chetwynd; W L Craig; J V Metcalf; O F W James
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 2.  Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  Laura Andreoli; Micaela Fredi; Cecilia Nalli; Rossella Reggia; Andrea Lojacono; Mario Motta; Angela Tincani
Journal:  J Autoimmun       Date:  2011-12-26       Impact factor: 7.094

Review 3.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

Authors:  T G Wegmann; H Lin; L Guilbert; T R Mosmann
Journal:  Immunol Today       Date:  1993-07

4.  Relationship between parity and clinical and biological features in patients with systemic sclerosis.

Authors:  D Launay; M Hebbar; P Y Hatron; U Michon-Pasturel; V Queyrel; E Hachulla; B Devulder
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

5.  Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort.

Authors:  Kristian Tore Jørgensen; Nete Munk Nielsen; Bo Vestergaard Pedersen; Søren Jacobsen; Morten Frisch
Journal:  J Autoimmun       Date:  2012-01-05       Impact factor: 7.094

Review 6.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

Review 7.  Primary biliary cirrhosis.

Authors:  Jayant A Talwalkar; Keith D Lindor
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

8.  B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases.

Authors:  Shirish R Sangle; Pamela M K Lutalo; Rachel J Davies; Munther A Khamashta; David P D'Cruz
Journal:  J Autoimmun       Date:  2013-04-19       Impact factor: 7.094

9.  Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris.

Authors:  Chez A Viall; Qi Chen; Bonnia Liu; Anthony Hickey; Saul Snowise; Jane E Salmon; Peter R Stone; Lawrence W Chamley
Journal:  J Autoimmun       Date:  2013-09-12       Impact factor: 7.094

Review 10.  Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy.

Authors:  Marvin Williams; Eliza F Chakravarty
Journal:  Curr Opin Rheumatol       Date:  2014-05       Impact factor: 5.006

View more
  13 in total

Review 1.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

2.  Unmet challenges in immune-mediated hepatobiliary diseases.

Authors:  Ulrich Beuers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 3.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

4.  Single Topic Conference on Autoimmune Liver Disease from the Canadian Association for the Study of the Liver.

Authors:  Aldo J Montano-Loza; Jessica R Allegretti; Angela Cheung; Maryam Ebadi; David Jones; Nanda Kerkar; Cynthia Levy; Sumera Rizvi; John M Vierling; Fernando Alvarez; Wayne Bai; Susan Gilmour; Aliya Gulamhusein; Orlee Guttman; Bettina E Hansen; Sonya MacParland; Andrew Mason; Fernanda Onofrio; Pere Santamaria; Ashley Stueck; Mark Swain; Catherine Vincent; Amanda Ricciuto; Gideon Hirschfield
Journal:  Can Liver J       Date:  2021-11-11

Review 5.  Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.

Authors:  Yu-Qing Xie; Hong-Di Ma; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 6.  Women and primary biliary cirrhosis.

Authors:  Ying Sun; Krista Haapanen; Baosen Li; Weici Zhang; Judy Van de Water; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 7.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

Review 8.  The Bach Family of Transcription Factors: A Comprehensive Review.

Authors:  Yin Zhou; Haijing Wu; Ming Zhao; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 10.817

Review 9.  Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective.

Authors:  Renée M Marchioni Beery; Haleh Vaziri; Faripour Forouhar
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

10.  APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.

Authors:  Hong You; Xiong Ma; Cumali Efe; Guiqiang Wang; Sook-Hyang Jeong; Kazumichi Abe; Weijia Duan; Sha Chen; Yuanyuan Kong; Dong Zhang; Lai Wei; Fu-Sheng Wang; Han-Chieh Lin; Jin Mo Yang; Tawesak Tanwandee; Rino A Gani; Diana A Payawal; Barjesh C Sharma; Jinlin Hou; Osamu Yokosuka; A Kadir Dokmeci; Darrell Crawford; Jia-Horng Kao; Teerha Piratvisuth; Dong Jin Suh; Laurentius A Lesmana; Jose Sollano; George Lau; Shiv K Sarin; Masao Omata; Atsushi Tanaka; Jidong Jia
Journal:  Hepatol Int       Date:  2022-02-04       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.